Citation Impact
58 standout
Citing Papers
New clinical trial design in precision medicine: discovery, development and direction
2024 Standout
Non-small-cell lung cancer
2024 Standout
Works of Derek Grose being referenced
PRIMUS-001: An adaptive phase II study of FOLFOX-A (FOLFOX and nab-paclitaxel) versus AG (nab-paclitaxel and gemcitabine) in patients with metastatic pancreatic cancer, with integrated biomarker evaluation (ISRCTN75002153) – Part of Precision-Panc.
2018
The impact of comorbidity upon determinants of outcome in patients with lung cancer
2014
Author Peers
| Author | PRM | Oncology | Otorhinolaryngology | RNMI | Last Decade | Papers | Cites |
|---|---|---|---|---|---|---|---|
| Derek Grose | 175 | 246 | 74 | 138 | 46 | 486 | |
| Ling-Hsia Wang | 4 | 2 | 2 | 51 | 41 | 280 | |
| Mona Askar | 4 | 133 | |||||
| Gertrud Krüskemper | 151 | 140 | 189 | 13 | 36 | 493 | |
| Ellis D. Evans | 26 | 927 | |||||
| Moddy Schain | 366 | 14 | 6 | 6 | 432 |
All Works
Login with ORCID to disown or claim papers
Loading papers...